Dr. Christopher Davies' lab focuses on understanding how the bacteria Neisseria gonorrhoeae becomes resistant to common antibiotics, particularly cephalosporins. By studying the mutations in a protein called PBP2, which plays a vital role in bacterial growth, the lab aims to uncover the molecular mechanisms behind this resistance. Ultimately, this research seeks to inform the development of new antibiotics to combat gonorrhea, a significant public health threat.